Ocuphire Pharma Inc
NASDAQ:OCUP

Watchlist Manager
Ocuphire Pharma Inc Logo
Ocuphire Pharma Inc
NASDAQ:OCUP
Watchlist
Price: 1.13 USD -3.42% Market Closed
Market Cap: 35.7m USD

Relative Value

The Relative Value of one OCUP stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.13 USD, Ocuphire Pharma Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OCUP Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
49
Median 3Y
2.2
Median 5Y
2.2
Industry
2.7
Forward
2.3
vs History
vs Industry
43
Median 3Y
-2.5
Median 5Y
-2.5
Industry
21.5
Forward
-1.2
vs History
vs Industry
48
Median 3Y
-3.1
Median 5Y
-3.4
Industry
16.7
vs History
vs Industry
34
Median 3Y
-3.1
Median 5Y
-3.4
Industry
23
vs History
71
vs Industry
64
Median 3Y
1.2
Median 5Y
2.4
Industry
2.3
vs History
vs Industry
91
Median 3Y
0.2
Median 5Y
-0.1
Industry
2.9
Forward
-0.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.6
vs History
19
vs Industry
55
Median 3Y
0.4
Median 5Y
-0.6
Industry
13.2
Forward
0.3
vs History
19
vs Industry
52
Median 3Y
0.4
Median 5Y
-0.6
Industry
16.6
Forward
0.2
vs History
19
vs Industry
56
Median 3Y
0.5
Median 5Y
-1.6
Industry
15.8
vs History
19
vs Industry
42
Median 3Y
0.5
Median 5Y
-1.6
Industry
19
vs History
vs Industry
62
Median 3Y
1.8
Median 5Y
-2.1
Industry
2

Multiples Across Competitors

OCUP Competitors Multiples
Ocuphire Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Ocuphire Pharma Inc
NASDAQ:OCUP
35.7m USD 2.2 -2.5 0.4 0.4
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.7 37.3 40
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
500.9B USD 5.4 19.9 16.3 21.1
CH
Roche Holding AG
SIX:ROG
262B CHF 4.3 27.8 11.9 13.8
UK
AstraZeneca PLC
LSE:AZN
213.4B GBP 5 30.7 108.6 158.9
CH
Novartis AG
SIX:NOVN
211.1B CHF 4.8 18.6 11.8 15.2
US
Merck & Co Inc
NYSE:MRK
265.8B USD 4.1 14 9.9 11.8
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.6 14 9.8 11.3
IE
Endo International PLC
LSE:0Y5F
212.8B USD 91.8 -72.8 337 845
US
Pfizer Inc
NYSE:PFE
142.2B USD 2.3 14.5 7.4 10.1
P/E Multiple
Earnings Growth PEG
US
Ocuphire Pharma Inc
NASDAQ:OCUP
Average P/E: 24.4
Negative Multiple: -2.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.7
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.8
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.7
37%
0.8
CH
Novartis AG
SIX:NOVN
18.6
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -72.8 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Ocuphire Pharma Inc
NASDAQ:OCUP
Average EV/EBITDA: 399.7
0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.3
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.6
10%
10.9
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
9.8
1%
9.8
IE
E
Endo International PLC
LSE:0Y5F
337
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Ocuphire Pharma Inc
NASDAQ:OCUP
Average EV/EBIT: 1 711.8
0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.9
23%
6.9
CH
Novartis AG
SIX:NOVN
15.2
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.8
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
845
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
7%
1.4